{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:02:34Z","timestamp":1784138554328,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19J23589"],"award-info":[{"award-number":["19J23589"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K14910"],"award-info":[{"award-number":["18K14910"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K06642"],"award-info":[{"award-number":["18K06642"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Kyoto Pharmaceutical University Fund for the promotion of Scientific Researc"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16fk0410107h0201"],"award-info":[{"award-number":["16fk0410107h0201"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Herpes simplex virus 1 (HSV-1) causes a number of clinical manifestations including cold sores, keratitis, meningitis and encephalitis. Although current drugs are available to treat HSV-1 infection, they can cause side effects such as nephrotoxicity. Moreover, owing to the emergence of drug-resistant HSV-1 strains, new anti-HSV-1 compounds are needed. Because many viruses exploit cellular host proteases and encode their own viral proteases for survival, we investigated the inhibitory effects of a panel of protease inhibitors (TLCK, TPCK, E64, bortezomib, or MG132) on HSV-1 replication and several host cell signaling pathways. We found that HSV-1 infection suppressed c-Raf-MEK1\/2-ERK1\/2-p90RSK signaling in host cells, which facilitated viral replication. The mechanism by which HSV-1 inhibited ERK signaling was mediated through the polyubiquitination and proteasomal degradation of Ras-guanine nucleotide-releasing factor 2 (Ras-GRF2). Importantly, the proteasome inhibitor MG132 inhibited HSV-1 replication by reversing ERK suppression in infected cells, inhibiting lytic genes (ICP5, ICP27 and UL42) expression, and overcoming the downregulation of Ras-GRF2. These results indicate that the suppression of ERK signaling via proteasomal degradation of Ras-GRF2 is necessary for HSV-1 infection and replication. Given that ERK activation by MG132 exhibits anti-HSV-1 activity, these results suggest that the proteasome inhibitor could serve as a novel therapeutic agent against HSV-1 infection.<\/jats:p>","DOI":"10.1038\/s41598-020-63438-1","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T10:04:37Z","timestamp":1587463477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["MG132 exerts anti-viral activity against HSV-1 by overcoming virus-mediated suppression of the ERK signaling pathway"],"prefix":"10.1038","volume":"10","author":[{"given":"Hanako","family":"Ishimaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riho","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2555-9375","authenticated-orcid":false,"given":"Tadashi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-0789","authenticated-orcid":false,"given":"Masahiro","family":"Fujimuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"63438_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","volume":"357","author":"RJ Whitley","year":"2001","unstructured":"Whitley, R. J. & Roizman, B. Herpes simplex virus infections. Lancet 357, 1513\u20131518 (2001).","journal-title":"Lancet"},{"key":"63438_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.hrtlng.2002.12.002","volume":"33","author":"LE Eisenstein","year":"2004","unstructured":"Eisenstein, L. E., Calio, A. J. & Cunha, B. A. Herpes simplex (HSV-1) aseptic meningitis. Heart Lung 33, 196\u2013197 (2004).","journal-title":"Heart Lung"},{"key":"63438_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-micro-092412-155654","volume":"67","author":"B Roizman","year":"2013","unstructured":"Roizman, B. & Whitley, R. J. An inquiry into the molecular basis of HSV latency and reactivation. Annu. Rev. Microbiol. 67, 355\u2013374 (2013).","journal-title":"Annu. Rev. Microbiol."},{"key":"63438_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.antiviral.2005.05.002","volume":"67","author":"MTH Khan","year":"2005","unstructured":"Khan, M. T. H., Ather, A., Thompson, K. D. & Gambari, R. Extracts and molecules from medicinal plants against Herpes simplex viruses. Antiviral Res. 67, 107\u2013119 (2005).","journal-title":"Antiviral Res."},{"key":"63438_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/QCO.0000000000000015","volume":"26","author":"G Andrei","year":"2013","unstructured":"Andrei, G. & Snoeck, R. Herpes simplex virus drug-resistance: new mutations and insights. Curr. Opin. Infect. Dis. 26, 551\u2013560 (2013).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"63438_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"ED Clercq","year":"2016","unstructured":"Clercq, E. D. & Li, G. Approved Antiviral Drugs over the Past 50 Years. Clin. Microbiol. Rev. 29, 695\u2013747 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"63438_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.coviro.2014.06.003","volume":"8","author":"SH James","year":"2014","unstructured":"James, S. H. & Prichard, M. N. Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance. Curr. Opin. Virol. 8, 54\u201361 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"63438_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1099\/vir.0.81541-0","volume":"87","author":"J Melchjorsen","year":"2006","unstructured":"Melchjorsen, J., Sir\u00e9n, J., Julkunen, I., Paludan, S. R. & Matikainen, S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J. Gen. Virol. 87, 1099\u20131108 (2006).","journal-title":"J. Gen. Virol."},{"key":"63438_CR9","doi-asserted-by":"publisher","first-page":"54586","DOI":"10.1371\/journal.pone.0054586","volume":"8","author":"M Cai","year":"2013","unstructured":"Cai, M. et al. The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-\u03baB through the toll-like receptor 2 and MyD88\/TRAF6-dependent signaling pathway. Plos One 8, 54586 (2013).","journal-title":"Plos One"},{"key":"63438_CR10","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1128\/JVI.00295-12","volume":"86","author":"V Leoni","year":"2012","unstructured":"Leoni, V., Gianni, T., Salvioli, S. & Campadelli-Fiume, G. Herpes simplex virus glycoproteins gH\/gL and gB bind Toll-like receptor 2, and soluble gH\/gL is sufficient to activate NF-\u03baB. J. Virol. 86, 6555\u20136562 (2012).","journal-title":"J. Virol."},{"key":"63438_CR11","doi-asserted-by":"publisher","first-page":"36059","DOI":"10.1074\/jbc.M306198200","volume":"278","author":"MA Medici","year":"2003","unstructured":"Medici, M. A. et al. Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB. J. Biol. Chem. 278, 36059\u201336067 (2003).","journal-title":"J. Biol. Chem."},{"key":"63438_CR12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.bcp.2008.07.030","volume":"76","author":"MT Sciortino","year":"2008","unstructured":"Sciortino, M. T. et al. Involvement of gD\/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD. Biochem. Pharmacol. 76, 1522\u20131532 (2008).","journal-title":"Biochem. Pharmacol."},{"key":"63438_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675\u2013680 (2001).","journal-title":"Nat. Immunol."},{"key":"63438_CR14","doi-asserted-by":"publisher","first-page":"17343","DOI":"10.1073\/pnas.0605102103","volume":"103","author":"A Sato","year":"2006","unstructured":"Sato, A., Linehan, M. M. & Iwasaki, A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. USA 103, 17343\u201317348 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63438_CR15","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1515\/BC.2008.145","volume":"389","author":"S Pleschka","year":"2008","unstructured":"Pleschka, S. RNA viruses and the mitogenic Raf\/MEK\/ERK signal transduction cascade. Biol. Chem. 389, 1273\u20131282 (2008).","journal-title":"Biol. Chem."},{"key":"63438_CR16","doi-asserted-by":"crossref","unstructured":"J\u00e4rviluoma, A. & Ojala, P. M. Cell signaling pathways engaged by KSHV. Biochim. Biophys. Acta 1766, 140\u2013158 (2006).","DOI":"10.1016\/j.bbcan.2006.05.001"},{"key":"63438_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/1471-2180-11-240","volume":"11","author":"D Qin","year":"2011","unstructured":"Qin, D. et al. Activation of PI3K\/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi\u2019s Sarcoma-associated herpesvirus by herpes simplex virus type 1. BMC Microbiol. 11, 240 (2011).","journal-title":"BMC Microbiol."},{"key":"63438_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1471-4159.2009.06475.x","volume":"112","author":"JM Laing","year":"2010","unstructured":"Laing, J. M., Smith, C. C. & Aurelian, L. Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K\/Akt and\/or MEK\/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine. J. Neurochem. 112, 662\u2013676 (2010).","journal-title":"J. Neurochem."},{"key":"63438_CR19","doi-asserted-by":"publisher","first-page":"7771","DOI":"10.1128\/JVI.00622-12","volume":"86","author":"U Chuluunbaatar","year":"2012","unstructured":"Chuluunbaatar, U., Roller, R. & Mohr, I. Suppression of extracellular signal-regulated kinase activity in herpes simplex virus 1-infected cells by the Us3 protein kinase. J. Virol. 86, 7771\u20137776 (2012).","journal-title":"J. Virol."},{"key":"63438_CR20","doi-asserted-by":"crossref","unstructured":"McLean, T. I. & Bachenheimer, S. L. Activation of cJun N-terminal kinase by herpes simplex virus type 1 enhances viral replication. J. Virol. 73, 8415\u20138426 (1999).","DOI":"10.1128\/JVI.73.10.8415-8426.1999"},{"key":"63438_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1101\/gad.1185304","volume":"18","author":"D Walsh","year":"2004","unstructured":"Walsh, D. & Mohr, I. Phosphorylation of eIF4E by Mnk1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev. 18, 660\u2013672 (2004).","journal-title":"Genes Dev."},{"key":"63438_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.virusres.2010.02.007","volume":"150","author":"H Zhang","year":"2010","unstructured":"Zhang, H. et al. Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2. Virus Res. 150, 22\u201327 (2010).","journal-title":"Virus Res."},{"key":"63438_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/35087061","volume":"3","author":"F Farassati","year":"2001","unstructured":"Farassati, F., Yang, A. D. & Lee, P. W. Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1. Nat. Cell Biol. 3, 745\u2013750 (2001).","journal-title":"Nat. Cell Biol."},{"key":"63438_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.antiviral.2012.05.002","volume":"95","author":"NI Torres","year":"2012","unstructured":"Torres, N. I. et al. In vitro antiviral activity of dehydroepiandrosterone, 17 synthetic analogs and ERK modulators against herpes simplex virus type 1. Antiviral Res. 95, 37\u201348 (2012).","journal-title":"Antiviral Res."},{"key":"63438_CR25","doi-asserted-by":"crossref","unstructured":"Ashizawa, A. et al. The Ubiquitin System and Kaposi\u2019s Sarcoma-Associated Herpesvirus. Front. Microbiol. 3, 66 (2012).","DOI":"10.3389\/fmicb.2012.00066"},{"key":"63438_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.virol.2005.09.044","volume":"344","author":"PD Bieniasz","year":"2006","unstructured":"Bieniasz, P. D. Late budding domains and host proteins in enveloped virus release. Virology 344, 55\u201363 (2006).","journal-title":"Virology"},{"key":"63438_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tim.2016.03.010","volume":"24","author":"NK Yilmaz","year":"2016","unstructured":"Yilmaz, N. K., Swanstrom, R. & Schiffer, C. A. Improving Viral Protease Inhibitors to Counter Drug Resistance. Trends Microbiol. 24, 547\u2013557 (2016).","journal-title":"Trends Microbiol."},{"key":"63438_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/CCO.0b013e328363dfee","volume":"25","author":"S Gantt","year":"2013","unstructured":"Gantt, S., Casper, C. & Ambinder, R. F. Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention. Curr. Opin. Oncol. 25, 495\u2013502 (2013).","journal-title":"Curr. Opin. Oncol."},{"key":"63438_CR29","unstructured":"di Meo, N., Bergamo, S., Dondas, A. & Trevisan, G. Bortezomib and bilateral herpes zoster. Acta dermatovenerol. Alp. Pannonica Adriat. 21, 21\u201322 (2012)."},{"key":"63438_CR30","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1128\/JVI.02236-09","volume":"84","author":"K Tran","year":"2010","unstructured":"Tran, K., Mahr, J. A. & Spector, D. H. Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription. J. Virol. 84, 3079\u20133093 (2010).","journal-title":"J. Virol."},{"key":"63438_CR31","doi-asserted-by":"crossref","unstructured":"Kaspari, M. et al. Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus. FEBS Lett. 582, 666\u2013672 (2008).","DOI":"10.1016\/j.febslet.2008.01.040"},{"key":"63438_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bbrc.2011.10.107","volume":"415","author":"C Saji","year":"2011","unstructured":"Saji, C. et al. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells. Biochem. Biophys. Res. Commun. 415, 573\u2013578 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"63438_CR33","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1128\/JVI.00267-11","volume":"85","author":"MG Delboy","year":"2011","unstructured":"Delboy, M. G. & Nicola, A. V. A pre-immediate-early role for tegument ICP0 in the proteasome-dependent entry of herpes simplex virus. J. Virol. 85, 5910\u20135918 (2011).","journal-title":"J. Virol."},{"key":"63438_CR34","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1128\/JVI.02296-07","volume":"82","author":"MG Delboy","year":"2008","unstructured":"Delboy, M. G., Roller, D. G. & Nicola, A. V. Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step. J. Virol. 82, 3381\u20133390 (2008).","journal-title":"J. Virol."},{"key":"63438_CR35","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts, P. J. & Der, C. J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291\u20133310 (2007).","journal-title":"Oncogene"},{"key":"63438_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrm3173","volume":"12","author":"AM Weissman","year":"2011","unstructured":"Weissman, A. M., Shabek, N. & Ciechanover, A. The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat. Rev. Mol. Cell Biol. 12, 605\u2013620 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"63438_CR37","doi-asserted-by":"publisher","first-page":"31707","DOI":"10.1074\/jbc.274.44.31707","volume":"274","author":"M Yokouchi","year":"1999","unstructured":"Yokouchi, M. et al. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J. Biol. Chem. 274, 31707\u201331712 (1999).","journal-title":"J. Biol. Chem."},{"key":"63438_CR38","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1128\/MCB.21.6.2107-2117.2001","volume":"21","author":"CL de Hoog","year":"2001","unstructured":"de Hoog, C. L. et al. Ras binding triggers ubiquitination of the Ras exchange factor Ras-GRF2. Mol. Cell. Biol. 21, 2107\u20132117 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"63438_CR39","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1128\/JVI.72.8.6581-6591.1998","volume":"72","author":"RD Everett","year":"1998","unstructured":"Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M. & Parkinson, J. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72, 6581\u20136591 (1998).","journal-title":"J. Virol."},{"key":"63438_CR40","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1093\/emboj\/17.24.7161","volume":"17","author":"RD Everett","year":"1998","unstructured":"Everett, R. D., Orr, A. & Preston, C. M. A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J. 17, 7161\u20137169 (1998).","journal-title":"EMBO J."},{"key":"63438_CR41","doi-asserted-by":"publisher","first-page":"e00732","DOI":"10.1128\/mBio.00732-19","volume":"10","author":"SM Schneider","year":"2019","unstructured":"Schneider, S. M., Pritchard, S. M., Wudiri, G. A., Trammell, C. E. & Nicola, A. V. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor. mBio 10, e00732\u201319 (2019).","journal-title":"mBio"},{"key":"63438_CR42","doi-asserted-by":"crossref","unstructured":"Paladino, P., Collins, S. E. & Mossman, K. L. Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. Plos One 5, e10428 (2010).","DOI":"10.1371\/journal.pone.0010428"},{"key":"63438_CR43","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1074\/mcp.M113.030866","volume":"12","author":"AE Lin","year":"2013","unstructured":"Lin, A. E., Greco, T. M., D\u00f6hner, K., Sodeik, B. & Cristea, I. M. A proteomic perspective of inbuilt viral protein regulation: pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection. Mol. Cell. Proteomics 12, 3237\u20133252 (2013).","journal-title":"Mol. Cell. Proteomics"},{"key":"63438_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1128\/JVI.02635-14","volume":"89","author":"SE Conwell","year":"2015","unstructured":"Conwell, S. E., White, A. E., Harper, J. W. & Knipe, D. M. Identification of TRIM27 as a novel degradation target of herpes simplex virus 1 ICP0. J. Virol. 89, 220\u2013229 (2015).","journal-title":"J. Virol."},{"key":"63438_CR45","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1074\/mcp.M116.064741","volume":"16","author":"MS Crow","year":"2017","unstructured":"Crow, M. S. & Cristea, I. M. Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation. Mol. Cell. Proteomics 16, S200\u2013S214 (2017).","journal-title":"Mol. Cell. Proteomics"},{"key":"63438_CR46","first-page":"e00402","volume":"92","author":"X Liu","year":"2018","unstructured":"Liu, X., Main, D., Ma, Y. & He, B. Herpes Simplex Virus 1 Inhibits TANK-Binding Kinase 1 through Formation of the Us11-Hsp90 Complex. J. Virol. 92, e00402\u201318 (2018).","journal-title":"J. Virol."},{"key":"63438_CR47","doi-asserted-by":"publisher","first-page":"e00839","DOI":"10.1128\/JVI.00839-18","volume":"92","author":"G Pastenkos","year":"2018","unstructured":"Pastenkos, G., Lee, B., Pritchard, S. M. & Nicola, A. V. Bovine Herpesvirus 1 Entry by a Low-pH Endosomal Pathway. J. Virol. 92, e00839\u201318 (2018).","journal-title":"J. Virol."},{"key":"63438_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep09730","volume":"5","author":"AM Yakoub","year":"2015","unstructured":"Yakoub, A. M. & Shukla, D. Autophagy stimulation abrogates herpes simplex virus-1 infection. Sci. Rep. 5, 9730 (2015).","journal-title":"Sci. Rep."},{"key":"63438_CR49","doi-asserted-by":"crossref","unstructured":"Colao, I., Pennisi, R., Venuti, A., Nyg\u00e5rdas, M., Heikkil\u00e4, O., Hukkanen, V. & Sciortino, M. T. The ERK-1 function is required for HSV-1-mediated G1\/S progression in HEP-2 cells and contributes to virus growth. Sci. Rep. 7, 9176 (2017).","DOI":"10.1038\/s41598-017-09529-y"},{"key":"63438_CR50","first-page":"79","volume":"289","author":"L Aurelian","year":"2005","unstructured":"Aurelian, L. HSV-induced apoptosis in herpes encephalitis. Curr. Top. Microbiol. Immunol 289, 79\u2013111 (2005).","journal-title":"Curr. Top. Microbiol. Immunol"},{"key":"63438_CR51","unstructured":"Roizman, B., Knipe, D. M. & Whitley, R. J. Herpes Simplex Viruses in Fields Virology, 6th Edition Vol. 2 (eds Knipe, D. M. & Howley, P. M.) Ch. 60, 1823\u20131897 (Lippincott Williams & Wilkins, 2013)."},{"key":"63438_CR52","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0960-9822(07)00376-4","volume":"8","author":"WT Fan","year":"1998","unstructured":"Fan, W. T., Koch, C. A., de Hoog, C. L., Fam, N. P. & Moran, M. F. The exchange factor Ras-GRF2 activates Ras-dependent and Rac-dependent mitogen-activated protein kinase pathways. Curr. Biol. 8, 935\u2013938 (1998).","journal-title":"Curr. Biol."},{"key":"63438_CR53","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1128\/MCB.17.3.1396","volume":"17","author":"NP Fam","year":"1997","unstructured":"Fam, N. P. et al. Cloning and characterization of Ras-GRF2, a novel exchange factor for Ras. Mol. Cell. Biol. 17, 1396\u20131406 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"63438_CR54","doi-asserted-by":"crossref","unstructured":"Umebayashi, K., Stenmark, H. & Yoshimori, T. Ubc4\/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation. Mol. Biol. Cell 19, 3454\u20133462 (2008).","DOI":"10.1091\/mbc.e07-10-0988"},{"key":"63438_CR55","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbrc.2016.07.111","volume":"479","author":"C Chung","year":"2016","unstructured":"Chung, C. et al. The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitinion and degradation. Biochem. Biophys. Res. Commun. 479, 152\u2013158 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"63438_CR56","doi-asserted-by":"publisher","first-page":"11335","DOI":"10.1073\/pnas.0801617105","volume":"105","author":"X Liu","year":"2008","unstructured":"Liu, X., Fitzgerald, K., Kurt-Jones, E., Finberg, R. & Knipe, D. M. Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein. Proc. Natl. Acad. Sci. USA 105, 11335\u201311339 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63438_CR57","doi-asserted-by":"publisher","first-page":"13582","DOI":"10.1128\/JVI.78.24.13582-13590.2004","volume":"78","author":"D Gregory","year":"2004","unstructured":"Gregory, D., Hargett, D., Holmes, D., Money, E. & Bachenheimer, S. L. Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway. J. Virol. 78, 13582\u201313590 (2004).","journal-title":"J. Virol."},{"key":"63438_CR58","doi-asserted-by":"publisher","first-page":"28759","DOI":"10.1074\/jbc.M103408200","volume":"276","author":"C Amici","year":"2001","unstructured":"Amici, C., Belardo, G., Rossi, A. & Santoro, M. G. Activation of I kappa b kinase by herpes simplex virus type 1, A novel target for anti-herpetic therapy. J. Biol. Chem. 276, 28759\u201328766 (2001).","journal-title":"J. Biol. Chem."},{"key":"63438_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cellsig.2004.07.003","volume":"17","author":"L Diao","year":"2005","unstructured":"Diao, L. et al. Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination. Cell Signal. 17, 217\u2013229 (2005).","journal-title":"Cell Signal."},{"key":"63438_CR60","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.antiviral.2006.06.011","volume":"72","author":"SA Faith","year":"2006","unstructured":"Faith, S. A., Sweet, T. J., Bailey, E., Booth, T. & Docherty, J. J. Resveratrol suppresses nuclear factor-kB in herpes simplex virus infected cells. Antiviral Res. 72, 242\u2013251 (2006).","journal-title":"Antiviral Res."},{"key":"63438_CR61","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/135965350601100805","volume":"11","author":"S La Frazia","year":"2006","unstructured":"La Frazia, S., Amici, C. & Santoro, M. G. Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB. Antivir. Ther. 11, 995\u20131004 (2006).","journal-title":"Antivir. Ther."},{"key":"63438_CR62","doi-asserted-by":"crossref","unstructured":"Nishimura, M., Watanabe, T., Yagi, S., Yamanaka, T. & Fujimuro, M. Kaposi\u2019s sarcoma-associated herpesvirus ORF34 is essential for late gene expression and virus production. Sci. Rep. 7, 329 (2017).","DOI":"10.1038\/s41598-017-00401-7"},{"key":"63438_CR63","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1128\/MCB.7.8.2745","volume":"7","author":"C Chen","year":"1987","unstructured":"Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745\u20132752 (1987).","journal-title":"Mol. Cell. Biol."},{"key":"63438_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2016.02.057","volume":"472","author":"S Nakata","year":"2016","unstructured":"Nakata, S. et al. The dynamics of histone H2A ubiquitination in HeLa cells exposed to rapamycin, ethanol, hydroxyurea, ER stress, heat shock and DNA damage. Biochem. Biophys. Res. Commun. 472, 46\u201352 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"63438_CR65","doi-asserted-by":"crossref","unstructured":"Fujimuro, M., Sawada, H. & Yokosawa, H. Production and characterization of monoclonal antibodies specific to multi-ubiquitin chains of polyubiquitinated proteins. FEBS Lett. 349, 173\u2013180 (1994).","DOI":"10.1016\/0014-5793(94)00647-4"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63438-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:37:04Z","timestamp":1670319424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63438-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63438"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63438-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"assertion":[{"value":"9 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6671"}}